- Home
- CDIO vs PULM Comparison
CDIO vs PULM Comparison
Compare CDIO & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- PULM
- Stock Information
- Founded
- CDIO 2017
- PULM 2003
- Country
- CDIO United States
- PULM United States
- Employees
- CDIO N/A
- PULM N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- CDIO Health Care
- PULM Health Care
- Exchange
- CDIO Nasdaq
- PULM Nasdaq
- Market Cap
- CDIO 20.2M
- PULM 21.0M
- IPO Year
- CDIO N/A
- PULM N/A
- Fundamental
- Price
- CDIO $0.50
- PULM $8.92
- Analyst Decision
- CDIO Buy
- PULM
- Analyst Count
- CDIO 1
- PULM 0
- Target Price
- CDIO $2.00
- PULM N/A
- AVG Volume (30 Days)
- CDIO 2.5M
- PULM 36.8K
- Earning Date
- CDIO 03-31-2025
- PULM 03-27-2025
- Dividend Yield
- CDIO N/A
- PULM N/A
- EPS Growth
- CDIO N/A
- PULM N/A
- EPS
- CDIO N/A
- PULM N/A
- Revenue
- CDIO $35,688.00
- PULM $10,005,000.00
- Revenue This Year
- CDIO $228.74
- PULM N/A
- Revenue Next Year
- CDIO $854.55
- PULM $1.00
- P/E Ratio
- CDIO N/A
- PULM N/A
- Revenue Growth
- CDIO 180.90
- PULM 47.05
- 52 Week Low
- CDIO $0.19
- PULM $1.55
- 52 Week High
- CDIO $1.86
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- CDIO 45.05
- PULM 62.72
- Support Level
- CDIO $0.47
- PULM $8.80
- Resistance Level
- CDIO $0.69
- PULM $10.40
- Average True Range (ATR)
- CDIO 0.08
- PULM 0.59
- MACD
- CDIO 0.01
- PULM 0.15
- Stochastic Oscillator
- CDIO 33.88
- PULM 56.21
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.